2003
PUK8 SEVELAMER USE IN HYPERPHOSPHATEMIA: HEALTH AND ECONOMIC CONSEQUENCES

JJ Caro , KF Huybrechts , DA Wilson , GM London
Value in Health 6 ( 6) 702

2
2003
PUK7 DITROPAN XL VERSUS DETROL IN CANADA: ECONOMIC ANALYSIS

D Getsios , JJ Caro , KJ Ishak , W El-Hadi
Value in Health 6 ( 6) 702

2003
PIN28 HOSPITAL MANAGEMENT OF PERTUSSIS IN GERMANY: COST PER CASE BY AGE

JA O'Brien , CA Pitoniak-Morse , JJ Caro
Value in Health 6 ( 6) 755 -756

2003
PMD31 ENSURING A STANDARD USER INTERFACE FOR MODELS: MODEL-IT

JJ Caro , LL Magno
Value in Health 6 ( 6) 803

2003
2004
PMH41 SUICIDE ATTEMPTS BY THE ELDERLY: HOSPITAL RESOURCE USE AND COSTS

J O'Brien , C Pitoniak-Morse , JJ Caro
Value in Health 7 ( 3) 276

1
2004
PUK3 DITROPAN XL PROVIDES SUPERIOR OUTCOMES AND LOWER COSTS COMPARED TO DETROL LA

W El-Hadi , D Getsios , W Feng , I Duchesne
Value in Health 7 ( 3) 363

1
2004
2016
PIN16 CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA (CDAD) IN ACUTE HOSPITALS: A PREVALENT COST ISSUE

JA O'Brien , C Pitoniak-Morse , BJ Lahue , D Davidson
Value in Health 9 ( 3)

2006
2007
PDB40 SIMULATION OF LONG-TERM COSTS OF COMPLICATIONS IN TYPE II DIABETES IN THE UNITED STATES

A Ward , T Kongnakorn , J Moller , JA O'Brien
Value in Health 10 ( 6)

1
2007